Table 1.
Gender | |
male | 19 |
female | 10 |
Age at diagnosis of nodal metastasis in years (median; range) |
74; 48–92 |
Immune status | |
immunocompromised | 4 |
not immunocompromised | 25 |
Smoking | |
yes | 12 |
no | 17 |
Recurrence | |
yes | 11 |
no | 18 |
Received radiation therapy | |
yes | 6 |
no | 23 |
Prior diagnosis of cSCC | |
yes | 12 |
no | 17 |
Progression-free survival in months (median; range) |
37; 1–130 |
Overall survival in months (median; range) |
60; 7–155 |